A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy

HIGHLIGHTS

• who: Panagis Galiatsatos from the USA USA USA USA have published the Article: A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy, in the Journal: (JOURNAL) of 27/07/2021
• what: In this systematic review the authors performed a search for English-language Articles identified through PubMed Embase and Scopus databases whose research occurred in the United States (US). The authors focused on number of patients recruited in intravenous bevacizumab trials who were identified by race or ethnicity. The aim of this study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.